Bellevue Medtech & Services AI

Reference Data

ISIN LU1916265082
Valor Number
Bloomberg Global ID
Fund Name Bellevue Medtech & Services AI
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies.
Peculiarities

Fund Prices

Current Price * 182.12 EUR 30.10.2024
Previous Price * 183.13 EUR 29.10.2024
52 Week High * 187.68 EUR 14.10.2024
52 Week Low * 147.90 EUR 10.11.2023
NAV * 182.12 EUR 30.10.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 1,551,905,516
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance +10.84% 29.12.2023
30.10.2024
YTD Performance (in CHF) +12.26% 29.12.2023
30.10.2024
1 month -1.16% 30.09.2024
30.10.2024
3 months +3.55% 30.07.2024
30.10.2024
6 months +3.96% 30.04.2024
30.10.2024
1 year +25.84% 30.10.2023
30.10.2024
2 years +5.58% 31.10.2022
30.10.2024
3 years -1.97% 02.11.2021
30.10.2024
5 years +10.17% 15.06.2021
30.10.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Boston Scientific Corp 9.83%
Intuitive Surgical Inc 9.79%
Abbott Laboratories 9.63%
Stryker Corp 8.91%
Medtronic PLC 4.88%
Becton Dickinson & Co 4.66%
Essilorluxottica 3.98%
Alcon Inc 3.88%
Edwards Lifesciences Corp 3.26%
GE HealthCare Technologies Inc Common Stock 2.53%
Last data update 31.08.2024

Cost / Risk

TER 1.53%
TER date 29.01.2021
Performance Fee ***
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.49%
SRRI ***
SRRI date *** 30.09.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)